Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenetix 350 in Coronary CT Angiography
NCT01255722Phase 4Completed
- Sponsor
- Guerbet
- Start
- Nov 2010
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of iobitridol in coronary artery disease (CAD), sponsored by Guerbet. Started Nov 2010; status: completed.
02
Drugs
iobitridol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01255722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01255722.